Callan Family Office’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.5M Buy
35,777
+162
+0.5% +$49.2K 0.3% 63
2026
Q1
$7.61M Sell
35,615
-17
-0% -$3.8K 0.17% 119
2025
Q4
$6.1M Buy
35,632
+10,718
+43% +$1.67M 0.13% 167
2025
Q3
$3.34M Sell
24,914
-1,255
-5% -$133K 0.11% 199
2025
Q2
$2.55M Buy
26,169
+14,354
+121% +$1.14M 0.08% 238
2025
Q1
$859K Sell
11,815
-2,307
-16% -$182K 0.06% 238
2024
Q4
$1.02M Buy
+14,122
New +$1.07M 0.06% 250

Other funds holding LRCX

Callan Family Office's LRCX Position: Q2 2026 in Review

Callan Family Office increased its Lam Research (LRCX) stake by 0.45% in Q2 2026, buying an estimated $49.2K and bringing the position to 35,777 shares worth $15.5M. The position accounts for 0.3% of the portfolio, ranked #63.

Callan Family Office first reported a position in LRCX in Q4 2024 and has held it in 7 quarters since. 3,114 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Callan Family Office held 35,777 shares of Lam Research worth $15.5M as of Q2 2026.
  • Callan Family Office bought 162 Lam Research shares in Q2 2026, an estimated $49.2K.
  • Lam Research made up 0.3% of Callan Family Office's portfolio in Q2 2026, its #63 holding.
  • Callan Family Office first reported a position in Lam Research in Q4 2024 and has held it in 7 quarters since.
  • 3,114 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.